Invariant p53 immunostaining in primary and recurrent breast cancer.


In animal models, acquired mutations of the p53 gene that result in increased p53 protein expression are associated with tumour recurrence following chemotherapy. The aim of this study was to test the hypothesis that breast cancer recurrences following adjuvant therapy exhibit aberrant p53 expression. We therefore evaluated p53 expression in paired primary… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.